摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2,2-二氯-1-(4-甲氧基苯基)环丙基]-4-甲氧基苯 | 22125-33-3

中文名称
1-[2,2-二氯-1-(4-甲氧基苯基)环丙基]-4-甲氧基苯
中文别名
——
英文名称
1-(p-methoxyphenyl)-1-(p-methoxyphenyl)-2,2-dichlorocyclopropane
英文别名
1,1-dichloro-2,2-bis(p-methoxyphenyl)cyclopropane;1,1-dichloro-2,2-Bis-(p-methoxyphenyl)-cyclopropane;1,1-dichloro-2,2-Bis-[(4-methoxy) phenyl]cyclopropane;1,1-dichloro-2,2-Bis-(p-methoxyphenyl) cyclopropane;1,1-dichloro-2,2-Bis-(p-methoxyphenyl)cyclopropane;1-[2,2-dichloro-1-(4-methoxyphenyl)cyclopropyl]-4-methoxybenzene
1-[2,2-二氯-1-(4-甲氧基苯基)环丙基]-4-甲氧基苯化学式
CAS
22125-33-3
化学式
C17H16Cl2O2
mdl
——
分子量
323.219
InChiKey
MBWGURPVLDNNAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Gem-dichlorocyclopropanes as antitumor agents
    申请人:Research Corporation Technologies, Inc.
    公开号:US05397802A1
    公开(公告)日:1995-03-14
    Gem-Dichlorocyclopropanes (Analog II derivatives) which demonstrate antiproliferative activity toward MCF-7 cells, in vitro and are generally not reversed by estradiol or having intrinsic estrogenicity (except the hydroxyphenyl derivative Compound 30). In general the cyclopropane compounds have the formula: ##STR1## or any pharmaceutically acceptable salt thereof. X is selected from a group consisting of hydrogen and halogen atoms. The group R.sub.1 may be a hydrogen atom, an alkyl group, an acyl group, or an arylalkyl group. The group R.sub.2 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The group R.sub.3 may be a hydrogen atom, an alkyl group, a cycloalkyl group, a substituted aryl group or an unsubstituted aryl group. The group R.sub.4 may be a hydrogen atom, an unsubstituted aryl group or a substituted aryl group. The R.sub.4 is absent when R.sub.3 is a cycloalkyl group having a first position carbon and a terminal position carbon bonded to the same carbon of the cyclopropane. Further, no more than any two of R.sub.2, R.sub.3 and R.sub.4 has an aryl group.
    Gem-Dichlorocyclopropanes(类比物II衍生物)在体外对MCF-7细胞表现出抗增殖活性,通常不会被雌二醇逆转或具有内在的雌激素作用(除羟基苯基衍生物化合物30外)。一般来说,环丙烷化合物的化学式为:##STR1##或其任何药学上可接受的盐。X选择自氢原子和卤素原子组成的一组。R.sub.1基团可以是氢原子,烷基,酰基或芳基烷基。R.sub.2基团可以是氢原子,未取代芳基或取代芳基。R.sub.3基团可以是氢原子,烷基,环烷基,取代芳基或未取代芳基。当R.sub.3是具有第一位置碳和终端位置碳与环丙烷的同一碳键合的环烷基时,R.sub.4缺失。此外,R.sub.2,R.sub.3和R.sub.4中最多有两个基团为芳基。
  • Diphenylcyclopropyl analogs
    申请人:Research Corporation Technologies
    公开号:US05658927A1
    公开(公告)日:1997-08-19
    Diphenylcyclopropyl analogs in which one or more of the phenyl rings includes alkoxy substituents including a dialkylaminoalkoxy group, an unsubstituted piperazine alkoxy group, a substituted piperazine alkoxy group, an unsubstituted piperidine alkoxy group, and a substituted piperidine alkoxy group, and which may have one or two alkyl groups bonded to the cyclopropane. The compounds are useful as antiestrogens and anti-tumor agents.
    二苯基环丙基类似物中,其中一个或多个苯环包括烷氧基取代基,包括二烷基基烷氧基、未取代哌嗪烷氧基、取代哌嗪烷氧基、未取代哌啶烷氧基和取代哌啶烷氧基,并且可以具有一个或两个烷基与环丙烷键合。这些化合物可用作抗雌激素和抗肿瘤剂。
  • Cyclopropyl analogs as anti-estrogenic, anti-tumor and female fertility
    申请人:The Board of Regents for the University of Oklahoma
    公开号:US04879315A1
    公开(公告)日:1989-11-07
    Anti-estrogenic cyclopropyl analogs such as 1,1-dichlorocis-2,3-diphenylcyclopropane, when administered to a subject function as anti-tumor agents to prevent the development of estrogen-dependent tumors in the subject and substantially arrest the growth and metastatic involvement of existing estrogen-dependent tumors in the subject. Further, the anti-estrogenic cyclopropyl analogs may be used as anti-estrogenic agents and as fertility agents in the treatment of female infertility. The cyclopropyl analogs useful as anti-tumor, anti-estrogenic and female fertility agents have the general structure ##STR1## wherein: X is a halogen or hydrogen atom; R.sub.1 is a hydrogen atom, an alkyl group containing from 1 to about 3 carbon atoms, a monocyclic group, a hydroxy substituted monocyclic group, an alkoxy substituted monocyclic group in which the alkyl substituent contains from 1 to about 3 carbon atoms or an acetoxy substituted monocyclic group; R.sub.2 is a hydrogen atom, an acetate group, a hydroxyl group, an alkoxy group in which the alkyl substituent contains from 1 to about 3 carbon atoms, a beta-dialkylaminoethoxy group wherein the alkyl substituent contains from 1 to about 6 carbon atoms, a beta-monoaminoheterocycloethoxy group, or pharmaceutically acceptable salts thereof; R.sub.3 is a hydrogen atom, an acetate group, a hydroxyl group, or an alkoxy group in which the alkyl substituent contains from 1 to about 3 carbon atoms; R.sub.4 is a hydrogen atom, or an alkyl group containing from 1 to about 3 carbon atoms; and the wavy lines ( ) in the structure indicate that the anti-tumor agent can be the cis- or trans-isomers.
    雌激素环丙基类似物,如1,1-二顺式-2,3-二苯基环丙烷,在给予受试者时作为抗肿瘤剂,以防止受试者发展雌激素依赖性肿瘤,并且在受试者中显著阻止现有雌激素依赖性肿瘤的生长和转移。此外,抗雌激素环丙基类似物可用作抗雌激素剂和用于治疗女性不孕症的生育剂。作为抗肿瘤、抗雌激素和女性生育剂的环丙基类似物具有一般结构##STR1##其中:X是卤素或氢原子;R.sub.1是氢原子、含有1到约3个碳原子的烷基、单环基、氢氧基取代的单环基、烷氧基取代的单环基,其中烷基取代基含有1到约3个碳原子或乙酰氧基取代的单环基;R.sub.2是氢原子、乙酸酯基、羟基、烷氧基,其中烷基取代基含有1到约3个碳原子、β-二烷基基乙氧基基,其中烷基取代基含有1到约6个碳原子、β-单胺杂环基乙氧基基,或其药学上可接受的盐;R.sub.3是氢原子、乙酸酯基、羟基或烷氧基,其中烷基取代基含有1到约3个碳原子;R.sub.4是氢原子或含有1到约3个碳原子的烷基;结构中的波浪线()表示抗肿瘤剂可以是顺式或反式异构体。
  • HIXSON, STEPHEN S.;FRANKE, LOTHAR A., J. ORG. CHEM., 53,(1988) N 12, 2706-2711
    作者:HIXSON, STEPHEN S.、FRANKE, LOTHAR A.
    DOI:——
    日期:——
  • US3962356A
    申请人:——
    公开号:US3962356A
    公开(公告)日:1976-06-08
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫